The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak spreads in dairy cows.

The US government is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine, hoping to bolster its pandemic jab stockpile as an H5N1 outbreak spreads ...

Moderna announced on Tuesday a deal with the US government to fund a late-stage trial of its pandemic bird flu vaccine. The announcement comes after months of speculation surrounding the Cambridge ...

Moderna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine, the Financial Times reported Thursday.. Millions of dollars of federal funding from the ...

Moderna Nears Bird Flu Vaccine Deal With U.S. As the H5N1 outbreak spreads from birds to cattle, Moderna will get government funding for a large-scale trial of its mRNA vaccine. BY REUTERS ...

The U.S. government is reportedly close to finalizing a deal with Moderna to fund its bird flu mRNA vaccine trial as concerns remain surrounding the outbreak in poultry and cattle. The Financial ...

Moderna shares climbed 2.5% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker’s experimental mRNA bird-flu vaccine.

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as it works to develop its product portfolio while cutting costs.

Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.